Keyphrases
Abdominal
24%
Abdominal MRI
25%
Active Learning
16%
Adverse Effects
18%
Artificial Intelligence
19%
Automatic Segmentation
21%
Cell nuclei Classification
25%
Colorectal Cancer
20%
Combined Expression
16%
Computational Pathology
18%
Context Features
13%
Crohn's Disease
100%
Deep Learning
29%
Deep Learning Methods
20%
Diagnostic Accuracy
15%
Diffuse Large B-cell Lymphoma (DLBCL)
16%
Digital Pathology
38%
Digital Slides
26%
Digital Workflow
12%
Disease Segmentation
16%
Disease Severity
17%
Fibronectin
12%
Glass Slide
20%
Graph Cuts
16%
Histopathological Images
24%
Image Compression
13%
ImageNet
16%
Immunohistochemistry
18%
Interobserver Agreement
15%
Lumbar Spinal Stenosis
16%
Magnetic Resonance Imaging
72%
Mass Spectrometry
12%
Multiple Kernel Learning
16%
Nuclei Classification
16%
Pathologist
63%
Prostate
17%
Prostate Cancer
22%
Protein Biomarkers
16%
Random Forest Classifier
15%
Renal Cell Carcinoma
37%
Semantic Information
13%
Semi-automatic
16%
Semi-supervised Learning
16%
Terminal Ileum
16%
Training Model
16%
Tumor
22%
Tumor-infiltrating Lymphocytes
18%
Whole Slide Image
62%
Whole-slide
25%
Whole-slide Imaging
16%
Medicine and Dentistry
Biological Marker
17%
Biopsy Technique
9%
Breast Carcinoma
8%
Burkitt's Lymphoma
11%
Cancer Classification
8%
Cancer Diagnosis
16%
Cancer Research
8%
Castration Resistant Prostate Cancer
8%
Cell Budding
8%
Colon
8%
Colorectal Carcinoma
16%
COVID-19
17%
Crohn's Disease
13%
Diagnosis
40%
Diagnostic Accuracy
10%
Diffuse Large B-Cell Lymphoma
16%
Diffusion MRI
8%
Digital Pathology
29%
Fibronectin
10%
Gastrointestinal Tract
8%
Gene Mutation
8%
Histopathology
16%
Hypoxia
8%
Immunoassay
8%
Lumbar Spinal Stenosis
16%
Lung
16%
Lung Cancer
8%
Magnetic Resonance Imaging
33%
Malignant Neoplasm
8%
Mass Cytometry
8%
Mass Spectrum
8%
Neoadjuvant Chemotherapy
8%
Neoplasm
39%
Osteonectin
8%
Osteosarcoma
8%
Pathologist
46%
Patient Care
10%
Patient with Crohn's Disease
8%
Pattern Recognition
8%
Prostate Cancer
30%
Prostatectomy
12%
Risk Stratification
8%
Squamous Cell Carcinoma
8%
Surgical Planning
8%
Systematic Review
9%
Terminal Ileum
16%
Treatment Response
8%
Tumor Cell
10%
Tumor Infiltrating Lymphocyte
16%
Tumour Heterogeneity
9%